Equine PotomavacTM
Neorickettsia Risticii Bacterin
Details
-
EQUINE POTOMAVAC vaccine to aid in the prevention of Potomac Horse Fever
-
Available monovalent or in combination with Rabies vaccine
-
It has been shown to be effective for the vaccination of healthy horses 3 months of age or older against Potomac Horse Fever (equine monocytic ehrlichiosis) due to Neorickettsia risticii.
-
Liquid suspension of inactivated Neorickettsia risticii
Features & Benefits
Features
-
Convenience and ease of use
Benefits
-
The safety and efficacy of this product have been demonstrated in controlled vaccination challenge tests and in thorough field evaluations
-
Safe for use for healthy horses, 3 months of age or older
Dosage & Administration
Shake well before use. Aseptically inject 1 mL (1 dose) intramuscularly (IM) into healthy horses 3 months of age or older.
Revaccinate with a second 1mL dose intramuscularly 3-4 weeks later.
Revaccinate annually or prior to anticipated exposure.
Resources
Safety Information
-
Store at 35-46°F (2-8°C)
-
Do not freeze
-
Do not mix with other products
-
Use entire contents when first opened
-
Shake well before using
-
Do not vaccinate within 21 days before slaughter
-
Contains gentamicin and thimerosal as preservatives
In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results. This product has not been tested in pregnant mares.
POTOMAVACTM is a trademark of Boehringer Ingelheim Animal Health USA Inc. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.